Daruruwan Dabbobi da ake karɓo a matsayin Sahabbai a Duniya

Hoton Jowanna Daley daga Pixabay
Written by Linda S. Hohnholz

Kamar yadda ake karɓar dabbobi da yawa a cikin waɗannan lokutan bala'in, ana sa ran kasuwar lafiyar dabbobi ta duniya za ta kai dalar Amurka biliyan 79.29 a cikin 2028 tare da yin rijistar tsayayyen kudaden shiga CAGR na 5.9% a kan lokacin hasashen, in ji sabon rahoton da Rahotanni da Bayanai suka buga. .

Print Friendly, PDF & Email

Mahimman abubuwan da ke haifar da haɓakar kudaden shiga na kasuwannin duniya sune yawaitar cututtukan zoonotic da cututtukan da ke haifar da abinci da cututtuka, haɓaka bincike da ayyukan ci gaba a cikin magungunan dabbobi, da ingantattun tsare-tsaren gwamnati.

Lafiyar dabbobi ta ƙunshi kula da dabbobi tare da yin rigakafin kan lokaci, duba lafiyar dabbobi na yau da kullun, da ziyarar kula da dabbobi. An yi amfani da dabbobi sosai don hanyoyin aikin gona, kiwon dabbobi, da kuma matsayin dabbobi a duk faɗin duniya tsawon ƙarni da yawa. Duk da haka, waɗannan dabbobin suna da saurin kamuwa da cututtuka daban-daban da cututtuka.

Masu dabbobi sun fahimci mahimmancin kula da lafiyar dabbobi ta hanyar yin gwaje-gwaje na yau da kullum don gano cututtuka da wuri-wuri. Tare da wannan, ƙungiyoyin jama'a da masu zaman kansu da yawa sun mayar da hankali kan samar da ingantattun wuraren jinya, da ba da kuɗin dakunan gwaje-gwajen bincike da ke aiki kan cututtukan dabbobi da cututtukan zoonotic.

'Yan wasan kasuwa daban-daban suna mai da hankali kan haɓaka samfuran kiwon lafiyar dabbobi masu tsada. Haɓaka kudaden shiga na kasuwannin duniya ana danganta su da dalilai kamar haɓaka shigar intanet da kasuwancin e-commerce, haɓaka adadin asibitocin likitocin dabbobi da asibitoci a duk faɗin duniya, da haɓaka saka hannun jari a ayyukan bincike da haɓakawa.

Koyaya, tsauraran ƙa'idodin gwamnati game da amincewa da magungunan dabbobi da rashin wayewa game da lafiyar dabbobi, da ƙarancin adadin ƙwayoyin cuta da ƙwayoyin cuta a cikin ƙasashe da yawa waɗanda ba su ci gaba ba wasu mahimman abubuwan da ake tsammanin za su iya kawo cikas ga haɓakar kudaden shiga na kasuwannin duniya yayin lokacin hasashen.

Wasu mahimman bayanai na rahoton:

  • Daga cikin nau'in samfurin, ana sa ran sashin binciken zai yi rijistar mafi girman kudaden shiga CAGR a cikin tsinkayar lokacin hasashen saboda karuwar yaduwar cututtuka daban-daban a cikin dabbobi, karuwar kashe kudaden kula da lafiyar dabbobi, karuwar adadin asibitocin dabbobi da asibitoci sanye da sabbin kayan aikin bincike da hanyoyin bincike.
  • Dangane da nau'in dabba, ana sa ran sashin dabbobin abokin yin rijistar saurin shiga CAGR tsakanin 2021 da 2028 saboda dalilai kamar haɓaka karɓar dabbobi don abokantaka a duk faɗin duniya, haɓaka sabis na dabbobi, da haɓaka wayar da kan jama'a game da lafiyar dabbobi da duba lafiyar yau da kullun. Bugu da kari, kudade na jama'a da masu zaman kansu don binciken likitan dabbobi da shirye-shiryen gwamnati don tallafawa kula da dabbobi a duniya suna haifar da karuwar kudaden shiga na sashin.
  • Dangane da amfani da ƙarshen, ana sa ran asibitocin dabbobi da sashin asibitoci za su sami mafi girman kaso na kudaden shiga yayin lokacin hasashen saboda haɓaka kayan aikin kiwon lafiyar dabbobi, hauhawar kamuwa da cututtuka da cututtuka daban-daban a cikin dabbobi, ƙara yawan gwaje-gwaje na yau da kullun, da samun sabbin abubuwa. magani da wuraren bincike a yawancin asibitocin dabbobi da asibitoci.
  • Ana sa ran Turai za ta yi rijistar ci gaban kudaden shiga a cikin lokacin hasashen saboda dalilai kamar haɓaka karɓar dabbobin abokantaka a duk faɗin yankin, yawan amfani da samfuran dabbobi, haɓaka yaduwar cututtukan dabbobi, samun ci gaba na bincike da sabis na jiyya.
  • Ana sa ran kudaden shiga kasuwannin Asiya Pasifik zai faɗaɗa a cikin sauri CAGR na 10% a lokacin annabta saboda yawaitar cututtukan zoonotic daban-daban, haɓaka ɗaukar dabbobi kamar karnuka da kuliyoyi tsakanin tsofaffi da yara, saurin birni, da haɓaka abin da za a iya zubarwa. kudin shiga. Bugu da kari, kara wayar da kan jama'a game da lafiyar dabbobi da dabbobi, bincike na yau da kullun da gwaji, da wadatar sabbin kayayyakin kiwon lafiyar dabbobi da kayan aikin tantancewa suna kara habaka kasuwannin Asiya Pacific.
  • Zoetis Inc., Ceva Santé Animale, Merck Animal Health, Vetoquinol SA, Boehringer Ingelheim International GmbH, Bayer AG, Virbac, Heska, Nutreco NV, Novartis International AG, Elanco Animal Health Inc., Biogenesis Bago SA, Thermo Fisher Scientific, Dectical Pharmaceu Plc., da Tianjin Ringpu Biotechnology Co Ltd. wasu manyan kamfanoni ne da ke aiki a kasuwar lafiyar dabbobi ta duniya.

 

Print Friendly, PDF & Email

Game da marubucin

Linda S. Hohnholz

Linda Hohnholz ta kasance babban edita don eTurboNews tsawon shekaru.
Tana son rubutawa kuma tana mai da hankali sosai ga cikakkun bayanai.
Har ila yau, ita ce ke kula da duk abubuwan da ke cikin ƙima da fitarwa.

Leave a Comment